IRF5 and breast cancer: Elucidating the function(s) of IRF5 within t-dEVs, and/or its contribution to the select packaging and secretion of t-dEVS, will provide critical insight into the clinical utility of IRF5 as a new therapeutic strategy to potentiate immunotherapy and inhibit metastasis of BC and OS, amongst others.